{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:09:45Z","timestamp":1793052585950,"version":"4.5.0"},"reference-count":119,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274211"],"award-info":[{"award-number":["82274211"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404927"],"award-info":[{"award-number":["82404927"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025T181057"],"award-info":[{"award-number":["2025T181057"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Colorectal cancer (CRC) is the third most prevalent malignancy worldwide and the second leading cause of cancer-associated deaths, posing a significant threat to human health. Given the limited therapeutic options and poor prognosis associated with CRC, there is an urgent need to develop new targeted therapeutic strategies to enhance clinical outcomes. The ubiquitin\u2013proteasome system (UPS), a central regulator for cellular protein homeostasis, plays a pivotal role in the initiation and progression of CRC. The UPS modulates several essential signaling pathways and is involved in regulating tumor immunity and resistance to chemotherapy. Thus, the UPS contributes significantly to the complex biological processes underlying CRC pathogenesis. In recent years, small-molecule compounds targeting the UPS have exhibited considerable therapeutic potential in CRC treatment. These drugs intervene in crucial steps in the UPS, such as the activity of E1, E2, and E3 enzymes, or directly target the proteasome, thereby regulating the degradation of oncogenic proteins and effectively impeding tumor progression. Moreover, emerging therapeutic strategies such as proteolysis-targeting chimera (PROTAC) and molecular glue technologies selectively degrade specific oncogenic proteins, thereby offering new avenues and promising opportunities for CRC treatment.<\/jats:p>","DOI":"10.1093\/jmcb\/mjaf027","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T11:52:06Z","timestamp":1755777126000},"source":"Crossref","is-referenced-by-count":8,"title":["Targeting the ubiquitin\u2013proteasome system and drug therapy in colorectal cancer"],"prefix":"10.1093","volume":"17","author":[{"given":"Ruixin","family":"Su","sequence":"first","affiliation":[{"name":"Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University , Tianjin 300070 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Shao","sequence":"additional","affiliation":[{"name":"School of Medicine, Nankai University , Tianjin 300071 ,","place":["China"]},{"name":"National Key Laboratory of Chinese Medicine Modernization, Tianjin University of Traditional Chinese Medicine , Tianjin 301617 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University , Tianjin 300070 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghui","family":"Liu","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University , Tianjin 300070 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitong","family":"Wang","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University , Tianjin 300070 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexin","family":"Kong","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University , Tianjin 300070 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Qiu","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University , Tianjin 300070 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"2026012711211435400_bib1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.molcel.2016.05.009","article-title":"MINDY-1 is a member of an evolutionarily conserved and structurally distinct new family of deubiquitinating enzymes","volume":"63","author":"Abdul","year":"2016","journal-title":"Mol. Cell"},{"key":"2026012711211435400_bib2","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/emboj\/16.13.3797","article-title":"\u03b2-catenin is a target for the ubiquitin\u2013proteasome pathway","volume":"16","author":"Aberle","year":"1997","journal-title":"EMBO J."},{"key":"2026012711211435400_bib2a","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2005.08.016","article-title":"The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation","volume":"123","author":"Adhikary","year":"2005","journal-title":"Cell"},{"key":"2026012711211435400_bib3","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1182\/blood-2008-12-195792","article-title":"Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired","volume":"114","author":"Ahmadzadeh","year":"2009","journal-title":"Blood"},{"key":"2026012711211435400_bib4","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00438-023-02029-x","article-title":"Clinical significance of SPOP and APC gene alterations in colorectal cancer in Indian population","volume":"298","author":"Ali","year":"2023","journal-title":"Mol. Genet. Genomics"},{"key":"2026012711211435400_bib5","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3390\/cancers12061579","article-title":"Advances in deubiquitinating enzyme inhibition and applications in cancer therapeutics","volume":"12","author":"Antao","year":"2020","journal-title":"Cancers"},{"key":"2026012711211435400_bib6","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1126\/science.1071809","article-title":"Signal transduction by the TGF-\u03b2 superfamily","volume":"296","author":"Attisano","year":"2002","journal-title":"Science"},{"key":"2026012711211435400_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cell.2014.06.013","article-title":"YAP\/TAZ incorporation in the \u03b2-catenin destruction complex orchestrates the Wnt response","volume":"158","author":"Azzolin","year":"2014","journal-title":"Cell"},{"key":"2026012711211435400_bib8","doi-asserted-by":"crossref","first-page":"c4354","DOI":"10.1126\/science.aac4354","article-title":"In vivo aspects of protein folding and quality control","volume":"353","author":"Balchin","year":"2016","journal-title":"Science"},{"key":"2026012711211435400_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbamcr.2013.02.028","article-title":"The ubiquitin proteasome system\u2014implications for cell cycle control and the targeted treatment of cancer","volume":"1843","author":"Bassermann","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"2026012711211435400_bib10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0092-8674(00)80929-0","article-title":"The proteasome: paradigm of a self-compartmentalizing protease","volume":"92","author":"Baumeister","year":"1998","journal-title":"Cell"},{"key":"2026012711211435400_bib11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tcb.2010.03.007","article-title":"Assembly, structure, and function of the 26S proteasome","volume":"20","author":"Bedford","year":"2010","journal-title":"Trends Cell Biol."},{"key":"2026012711211435400_bib12","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1021\/acscentsci.0c00411","article-title":"Targeted degradation of oncogenic KRASG12C by VHL-recruiting PROTACs","volume":"6","author":"Bond","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"2026012711211435400_bib13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cell.2019.11.031","article-title":"Proteolysis-targeting chimeras as therapeutics and tools for biological discovery","volume":"181","author":"Burslem","year":"2020","journal-title":"Cell"},{"key":"2026012711211435400_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41392-024-01907-z","article-title":"MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer","volume":"9","author":"Casacuberta","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"2026012711211435400_bib15","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41420-023-01760-z","article-title":"The involvement of E3 ubiquitin ligases in the development and progression of colorectal cancer","volume":"9","author":"Chen","year":"2023","journal-title":"Cell Death Discov."},{"key":"2026012711211435400_bib16","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/abbs\/gmaa053","article-title":"The application of ubiquitin ligases in the PROTAC drug design","volume":"52","author":"Chen","year":"2020","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"2026012711211435400_bib17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.omto.2022.10.012","article-title":"PROTACs in gastrointestinal cancers","volume":"27","author":"Chen","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"2026012711211435400_bib18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.biopha.2018.11.082","article-title":"Therapeutic potential of targeting the Wnt\/\u03b2-catenin signaling pathway in colorectal cancer","volume":"110","author":"Cheng","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"2026012711211435400_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0092-8674(94)90396-4","article-title":"The ubiquitin\u2013proteasome proteolytic pathway","volume":"79","author":"Ciechanover","year":"1994","journal-title":"Cell"},{"key":"2026012711211435400_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/CAD.0b013e328342fedb","article-title":"Antiproteasomal agents in rectal cancer","volume":"22","author":"Conrad","year":"2011","journal-title":"Anticancer Drugs"},{"key":"2026012711211435400_bib21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.tibs.2018.06.003","article-title":"Is \u03b2-catenin a druggable target for cancer therapy?","volume":"43","author":"Cui","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"2026012711211435400_bib22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4155\/fmc.11.187","article-title":"Targeting the ubiquitin\u2013proteasome pathway with inorganic compounds to fight cancer: a challenge for the future","volume":"4","author":"Dalla","year":"2012","journal-title":"Future Med. Chem."},{"key":"2026012711211435400_bib23","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.biocel.2012.07.011","article-title":"Proteasome deubiquitinases as novel targets for cancer therapy","volume":"44","author":"D'Arcy","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2026012711211435400_bib24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cell.2007.05.007","article-title":"Proteasomes: machines for all reasons","volume":"129","author":"Demartino","year":"2007","journal-title":"Cell"},{"key":"2026012711211435400_bib25","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1242\/dev.01316","article-title":"Maternal \u03b2-catenin and E-cadherin in mouse development","volume":"131","author":"De Vries","year":"2004","journal-title":"Development"},{"key":"2026012711211435400_bib26","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1039\/D2CS00387B","article-title":"Discovery of small molecule ligands for the von Hippel\u2013Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders","volume":"51","author":"Diehl","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"2026012711211435400_bib27","doi-asserted-by":"crossref","first-page":"109394","DOI":"10.1016\/j.celrep.2021.109394","article-title":"Degradation of CCNK\/CDK12 is a druggable vulnerability of colorectal cancer","volume":"36","author":"Dieter","year":"2021","journal-title":"Cell Rep."},{"key":"2026012711211435400_bib28","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrm2767","article-title":"Ubiquitin-binding domains\u2014from structures to functions","volume":"10","author":"Dikic","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2026012711211435400_bib29","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.gendis.2022.01.002","article-title":"Emerging role of ubiquitination\/deubiquitination modification of PD-1\/PD-L1 in cancer immunotherapy","volume":"10","author":"Ding","year":"2023","journal-title":"Genes Dis."},{"key":"2026012711211435400_bib30","doi-asserted-by":"crossref","first-page":"10606","DOI":"10.1021\/acs.jmedchem.1c00895","article-title":"Molecular glues for targeted protein degradation: from serendipity to rational discovery","volume":"64","author":"Dong","year":"2021","journal-title":"J. Med. Chem."},{"key":"2026012711211435400_bib31","doi-asserted-by":"crossref","first-page":"114643","DOI":"10.1016\/j.biopha.2023.114643","article-title":"Overcoming cancer multi-drug resistance (MDR): reasons, mechanisms, nanotherapeutic solutions, and challenges","volume":"162","author":"Duan","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"2026012711211435400_bib32","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1080\/15384047.2019.1638677","article-title":"MDM2 inhibitor RG7388 potently inhibits tumors by activating p53 pathway in nasopharyngeal carcinoma","volume":"20","author":"Fan","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"2026012711211435400_bib33","first-page":"1546","article-title":"A field guide to ubiquitylation","volume":"61","author":"Fang","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"2026012711211435400_bib34","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3390\/cancers13071513","article-title":"Dysregulation of the ubiquitin proteasome system in human malignancies: a window for therapeutic intervention","volume":"13","author":"Fhu","year":"2021","journal-title":"Cancers"},{"key":"2026012711211435400_bib35","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.drudis.2022.06.009","article-title":"Deubiquitinating enzymes: promising targets for drug resistance","volume":"27","author":"Ge","year":"2022","journal-title":"Drug Discov. Today"},{"key":"2026012711211435400_bib36","first-page":"131","article-title":"New insights into the mechanisms and importance of the proteasome in intracellular protein degradation","volume":"378","author":"Goldberg","year":"1997","journal-title":"Biol. Chem."},{"key":"2026012711211435400_bib37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/386463a0","article-title":"Structure of 20S proteasome from yeast at 2.4 A resolution","volume":"386","author":"Groll","year":"1997","journal-title":"Nature"},{"key":"2026012711211435400_bib38","doi-asserted-by":"crossref","first-page":"104161","DOI":"10.1016\/j.drudis.2024.104161","article-title":"P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators","volume":"29","author":"Guo","year":"2024","journal-title":"Drug Discov. Today"},{"key":"2026012711211435400_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fcell.2018.00011","article-title":"Delineating crosstalk mechanisms of the ubiquitin proteasome system that regulate apoptosis","volume":"6","author":"Gupta","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"2026012711211435400_bib40","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1242\/dev.01117","article-title":"LDL receptor-related proteins 5 and 6 in Wnt\/\u03b2-catenin signaling: arrows point the way","volume":"131","author":"He","year":"2004","journal-title":"Development"},{"key":"2026012711211435400_bib41","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41467-018-03148-5","article-title":"A family of unconventional deubiquitinases with modular chain specificity determinants","volume":"9","author":"Hermanns","year":"2018","journal-title":"Nat. Commun."},{"key":"2026012711211435400_bib42","doi-asserted-by":"crossref","first-page":"188556","DOI":"10.1016\/j.bbcan.2021.188556","article-title":"Tumor suppressor p53: biology, signaling pathways, and therapeutic targeting","volume":"1876","author":"Hernandez","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"2026012711211435400_bib43","doi-asserted-by":"crossref","first-page":"8206","DOI":"10.1016\/S0021-9258(20)82050-X","article-title":"Components of ubiquitin\u2013protein ligase system. Resolution, affinity purification, and role in protein breakdown","volume":"258","author":"Hershko","year":"1983","journal-title":"J. Biol. Chem."},{"key":"2026012711211435400_bib44","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/cr.2016.31","article-title":"Drugging the undruggables: exploring the ubiquitin system for drug development","volume":"26","author":"Huang","year":"2016","journal-title":"Cell Res."},{"key":"2026012711211435400_bib45","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1177\/2472555220965528","article-title":"E3 Ligase ligands for PROTACs: how they were found and how to discover new ones","volume":"26","author":"Ishida","year":"2021","journal-title":"SLAS Discov."},{"key":"2026012711211435400_bib46","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jb\/mvad113","article-title":"Protein degraders\u2014from thalidomide to new PROTACs","volume":"175","author":"Ito","year":"2024","journal-title":"J. Biochem."},{"key":"2026012711211435400_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-021-01474-9","article-title":"CircIL4R activates the PI3K\/AKT signaling pathway via the miR-761\/TRIM29\/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer","volume":"20","author":"Jiang","year":"2021","journal-title":"Mol. Cancer"},{"key":"2026012711211435400_bib48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1021\/acsmedchemlett.9b00584","article-title":"PROTAC-mediated degradation of KRAS protein for anticancer therapeutics","volume":"11","author":"Kargbo","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"2026012711211435400_bib49","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s12272-023-01455-0","article-title":"Ubiquitin\u2013proteasome system as a target for anticancer treatment\u2014an update","volume":"46","author":"Kim","year":"2023","journal-title":"Arch. Pharm. Res."},{"key":"2026012711211435400_bib50","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrm2731","article-title":"Breaking the chains: structure and function of the deubiquitinases","volume":"10","author":"Komander","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2026012711211435400_bib51","doi-asserted-by":"crossref","first-page":"e1000131","DOI":"10.1371\/journal.pgen.1000131","article-title":"E1 ubiquitin-activating enzyme UBA-1 plays multiple roles throughout C. elegans development","volume":"4","author":"Kulkarni","year":"2008","journal-title":"PLoS Genet."},{"key":"2026012711211435400_bib52","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.18632\/oncotarget.2431","article-title":"Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities","volume":"5","author":"Landre","year":"2014","journal-title":"Oncotarget"},{"key":"2026012711211435400_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molcel.2021.10.027","article-title":"Deubiquitinases: from mechanisms to their inhibition by small molecules","volume":"82","author":"Lange","year":"2022","journal-title":"Mol. Cell"},{"key":"2026012711211435400_bib54","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.3390\/cancers13123079","article-title":"Targeting the ubiquitin\u2013proteasome system for cancer therapeutics by small-molecule inhibitors","volume":"13","author":"LaPlante","year":"2021","journal-title":"Cancers"},{"key":"2026012711211435400_bib56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jbior.2018.01.001","article-title":"Interaction of the Wnt\/\u03b2-catenin and RAS\u2013ERK pathways involving co-stabilization of both \u03b2-catenin and RAS plays important roles in the colorectal tumorigenesis","volume":"68","author":"Lee","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"2026012711211435400_bib57","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/17460441.2024.2306845","article-title":"Molecular glue degraders: exciting opportunities for novel drug discovery","volume":"19","author":"Lemaitre","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"key":"2026012711211435400_bib58","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12943-021-01434-3","article-title":"Proteolysis-targeting chimeras (PROTACs) in cancer therapy","volume":"21","author":"Li","year":"2022","journal-title":"Mol. Cancer"},{"key":"2026012711211435400_bib59","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3390\/cells11050851","article-title":"Ubiquitination\u2013proteasome system (UPS) and autophagy two main protein degradation machineries in response to cell stress","volume":"11","author":"Li","year":"2022","journal-title":"Cells"},{"key":"2026012711211435400_bib60","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12967-023-04120-8","article-title":"Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt\/\u03b2-catenin\/c-Myc\/SOX2 pathway in colorectal cancer","volume":"21","author":"Li","year":"2023","journal-title":"J. Transl. Med."},{"key":"2026012711211435400_bib61","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1084\/jem.20092641","article-title":"MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-\u03baB signaling","volume":"207","author":"Liang","year":"2010","journal-title":"J. Exp. Med."},{"key":"2026012711211435400_bib62","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41421-020-0171-1","article-title":"A PROTAC peptide induces durable \u03b2-catenin degradation and suppresses Wnt-dependent intestinal cancer","volume":"6","author":"Liao","year":"2020","journal-title":"Cell Discov."},{"key":"2026012711211435400_bib58a","doi-asserted-by":"crossref","first-page":"6822","DOI":"10.1111\/jcmm.15336","article-title":"Trametinib potentiates TRAIL-induced apoptosis via FBW7-dependent Mcl-1 degradation in colorectal cancer cells","volume":"24","author":"Lin","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"2026012711211435400_bib63","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1073\/pnas.96.11.6273","article-title":"\u03b2-trcp couples \u03b2-catenin phosphorylation\u2013degradation and regulates Xenopus axis formation","volume":"96","author":"Liu","year":"1999","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026012711211435400_bib64","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","article-title":"Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"2026012711211435400_bib65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/\u03b2-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev. Cell"},{"key":"2026012711211435400_bib66","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1200\/JCO.2005.05.081","article-title":"The ubiquitin\u2013proteasome pathway and its role in cancer","volume":"23","author":"Mani","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"2026012711211435400_bib67","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1139\/o02-161","article-title":"TGF-\u03b2 and the Smad signal transduction pathway","volume":"80","author":"Mehra","year":"2002","journal-title":"Biochem. Cell. Biol."},{"key":"2026012711211435400_bib68","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1038\/sj.onc.1202642","article-title":"Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis","volume":"18","author":"Miyaki","year":"1999","journal-title":"Oncogene"},{"key":"2026012711211435400_bib69","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10555-017-9697-6","article-title":"Proteasome-associated deubiquitinases and cancer","volume":"36","author":"Mofers","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"2026012711211435400_bib70","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3390\/pharmaceutics15020411","article-title":"Cancer-specific delivery of proteolysis-targeting chimeras (PROTACs) and their application to cancer immunotherapy","volume":"15","author":"Moon","year":"2023","journal-title":"Pharmaceutics"},{"key":"2026012711211435400_bib70a","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.1111\/ajco.13744","article-title":"A phase I study of LCL161, a novel oral pan-inhibitor of apoptosis protein (IAP) antagonist, in Japanese patients with advanced solid tumors","volume":"18","author":"Morita","year":"2022","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"2026012711211435400_bib71","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mce.2015.05.029","article-title":"Ubiquitin specific protease 2 acts as a key modulator for the regulation of cell cycle by adiponectin and leptin in cancer cells","volume":"412","author":"Nepal","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"2026012711211435400_bib72","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.cell.2005.11.007","article-title":"A genomic and functional inventory of deubiquitinating enzymes","volume":"123","author":"Nijman","year":"2005","journal-title":"Cell"},{"key":"2026012711211435400_bib73","first-page":"4167","article-title":"UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme","volume":"63","author":"Okamoto","year":"2003","journal-title":"Cancer Res."},{"key":"2026012711211435400_bib74","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/jnci\/djh219","article-title":"Associations among \u03b2-TrCP, an E3 ubiquitin ligase receptor, \u03b2-catenin, and NF-\u03baB in colorectal cancer","volume":"96","author":"Ougolkov","year":"2004","journal-title":"J. Natl Cancer Inst."},{"key":"2026012711211435400_bib75","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s12272-020-01281-8","article-title":"Ubiquitin\u2013proteasome system (UPS) as a target for anticancer treatment","volume":"43","author":"Park","year":"2020","journal-title":"Arch. Pharm. Res."},{"key":"2026012711211435400_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2018.03.002","article-title":"Next-generation proteasome inhibitors for cancer therapy","volume":"198","author":"Park","year":"2018","journal-title":"Transl. Res."},{"key":"2026012711211435400_bib77","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3390\/cells12081110","article-title":"A new wave of targeting \u2018undruggable\u2019 Wnt signaling for cancer therapy: challenges and opportunities","volume":"12","author":"Park","year":"2023","journal-title":"Cells"},{"key":"2026012711211435400_bib78","doi-asserted-by":"crossref","first-page":"23010","DOI":"10.1074\/jbc.C700111200","article-title":"UBE1L2, a novel E1 enzyme specific for ubiquitin","volume":"282","author":"Pelzer","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2026012711211435400_bib79","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamcr.2004.09.019","article-title":"Ubiquitin: structures, functions, mechanisms","volume":"1695","author":"Pickart","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"2026012711211435400_bib80","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.sbi.2020.10.009","article-title":"Building ubiquitination machineries: E3 ligase multi-subunit assembly and substrate targeting by PROTACs and molecular glues","volume":"67","author":"Ramachandran","year":"2021","journal-title":"Curr. Opin. Struct. Biol."},{"key":"2026012711211435400_bib81","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrm.2017.83","article-title":"Ubiquitylation at the crossroads of development and disease","volume":"19","author":"Rape","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2026012711211435400_bib82","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41416-021-01389-8","article-title":"Phase 1 study of single-agent WNT974, a first-in-class porcupine inhibitor, in patients with advanced solid tumours","volume":"125","author":"Rodon","year":"2021","journal-title":"Br. J. Cancer"},{"key":"2026012711211435400_bib83","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-1-61779-474-2_22","article-title":"Assembly and function of the proteasome","volume":"832","author":"Saeki","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"2026012711211435400_bib84","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: chimeric molecules that target proteins to the Skp1\u2013Cullin-F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026012711211435400_bib85","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.semcancer.2018.01.016","article-title":"Targeting the RAS-dependent chemoresistance: the Warburg connection","volume":"54","author":"Serna-Blasco","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"2026012711211435400_bib85a","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1755-148X.2009.00628.x","article-title":"Inhibition of Siah2 ubiquitin ligase by vitamin K3 (menadione) attenuates hypoxia and MAPK signaling and blocks melanoma tumorigenesis","volume":"22","author":"Shah","year":"2009","journal-title":"Pigment Cell Melanoma Res."},{"key":"2026012711211435400_bib86","doi-asserted-by":"crossref","first-page":"11971","DOI":"10.3390\/ijms222111971","article-title":"Pharmacological modulation of ubiquitin\u2013proteasome pathways in oncogenic signaling","volume":"22","author":"Sharma","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"2026012711211435400_bib87","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/s41467-019-09358-9","article-title":"Prospective discovery of small molecule enhancers of an E3 ligase\u2013substrate interaction","volume":"10","author":"Simonetta","year":"2019","journal-title":"Nat. Commun."},{"key":"2026012711211435400_bib88","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev.arplant.55.031903.141801","article-title":"The ubiquitin 26S proteasome proteolytic pathway","volume":"55","author":"Smalle","year":"2004","journal-title":"Annu. Rev. Plant Biol."},{"key":"2026012711211435400_bib89","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41467-018-08027-7","article-title":"Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase","volume":"10","author":"Smith","year":"2019","journal-title":"Nat. Commun."},{"key":"2026012711211435400_bib90","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3390\/biomedicines11020478","article-title":"The role of HECT E3 ubiquitin ligases in colorectal cancer","volume":"11","author":"Sun","year":"2023","journal-title":"Biomedicines"},{"key":"2026012711211435400_bib91","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-020-01262-x","article-title":"The role of ubiquitination and deubiquitination in cancer metabolism","volume":"19","author":"Sun","year":"2020","journal-title":"Mol. Cancer"},{"key":"2026012711211435400_bib92","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/cr.2016.39","article-title":"Ubiquitin modifications","volume":"26","author":"Swatek","year":"2016","journal-title":"Cell Res."},{"key":"2026012711211435400_bib93","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nature05731","article-title":"Mechanism of auxin perception by the TIR1 ubiquitin ligase","volume":"446","author":"Tan","year":"2007","journal-title":"Nature"},{"key":"2026012711211435400_bib94","doi-asserted-by":"crossref","first-page":"1110712","DOI":"10.1016\/j.isci.2024.110712","article-title":"Molecular glue-mediated targeted protein degradation: a novel strategy in small-molecule drug development","volume":"27","author":"Tan","year":"2024","journal-title":"iScience"},{"key":"2026012711211435400_bib95","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13046-020-01690-z","article-title":"TM4SF1 promotes EMT and cancer stemness via the Wnt\/\u03b2-catenin\/SOX2 pathway in colorectal cancer","volume":"39","author":"Tang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2026012711211435400_bib96","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/ncb2314","article-title":"Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells","volume":"13","author":"Ten","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"2026012711211435400_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11658-020-00245-6","article-title":"Beyond K48 and K63: non-canonical protein ubiquitination","volume":"26","author":"Tracz","year":"2021","journal-title":"Cell. Mol. Biol. Lett."},{"key":"2026012711211435400_bib98","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/bs.ircmb.2014.09.002","article-title":"The amazing ubiquitin\u2013proteasome system: structural components and implication in aging","volume":"314","author":"Tsakiri","year":"2015","journal-title":"Int. Rev. Cell. Mol. Biol."},{"key":"2026012711211435400_bib99","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1582-4934.2007.00032.x","article-title":"Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin\u2013proteasome system and Cox-2","volume":"11","author":"Voutsadakis","year":"2007","journal-title":"J. Cell. Mol. Med."},{"key":"2026012711211435400_bib100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc3430","article-title":"MDM2, MDMX and p53 in oncogenesis and cancer therapy","volume":"13","author":"Wade","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"2026012711211435400_bib101","doi-asserted-by":"crossref","first-page":"129864","DOI":"10.1016\/j.ijbiomac.2024.129864","article-title":"PROTAC\u2013biomacromolecule conjugates for precise protein degradation in cancer therapy: a review","volume":"261","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"2026012711211435400_bib102","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.3390\/cancers15082385","article-title":"The ubiquitin\u2013proteasome system in tumor metabolism","volume":"15","author":"Wang","year":"2023","journal-title":"Cancers"},{"key":"2026012711211435400_bib103","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.apsb.2019.08.001","article-title":"Degradation of proteins by PROTACs and other strategies","volume":"10","author":"Wang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"2026012711211435400_bib103a","doi-asserted-by":"crossref","first-page":"9085","DOI":"10.1073\/pnas.0402770101","article-title":"The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation","volume":"101","author":"Welcker","year":"2004","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026012711211435400_bib106","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1096\/fasebj.11.14.9409543","article-title":"Regulation of ubiquitin-dependent processes by deubiquitinating enzymes","volume":"11","author":"Wilkinson","year":"1997","journal-title":"FASEB J."},{"key":"2026012711211435400_bib107","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/MCB.01737-08","article-title":"CHIP represses myocardin-induced smooth muscle cell differentiation via ubiquitin-mediated proteasomal degradation","volume":"29","author":"Xie","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"2026012711211435400_bib108","doi-asserted-by":"crossref","first-page":"116725","DOI":"10.1016\/j.ejmech.2024.116725","article-title":"PROTAC technology: from drug development to probe technology for target deconvolution","volume":"276","author":"Yan","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"2026012711211435400_bib109","doi-asserted-by":"crossref","first-page":"822745","DOI":"10.3389\/fonc.2021.822745","article-title":"Interaction of ncRNA and epigenetic modifications in gastric cancer: focus on histone modification","volume":"11","author":"Yang","year":"2021","journal-title":"Front. Oncol."},{"key":"2026012711211435400_bib109a","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/path.4502","article-title":"Erbin interacts with c-Cbl and promotes tumourigenesis and tumour growth in colorectal cancer by preventing c-Cbl-mediated ubiquitination and down-regulation of EGFR","volume":"236","author":"Yao","year":"2015","journal-title":"J. Pathol."},{"key":"2026012711211435400_bib110","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrm2780","article-title":"Building ubiquitin chains: E2 enzymes at work","volume":"10","author":"Ye","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2026012711211435400_bib111","doi-asserted-by":"crossref","first-page":"e175265","DOI":"10.1172\/JCI175265","article-title":"Induced protein degradation for therapeutics: past, present, and future","volume":"134","author":"Yoon","year":"2024","journal-title":"J. Clin. Invest."},{"key":"2026012711211435400_bib112","doi-asserted-by":"crossref","first-page":"e2111896119","DOI":"10.1073\/pnas.2111896119","article-title":"The NEDD8-activating enzyme inhibitor MLN4924 reduces ischemic brain injury in mice","volume":"119","author":"Yu","year":"2022","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026012711211435400_bib113","doi-asserted-by":"crossref","first-page":"1164656","DOI":"10.3389\/fmed.2023.1164656","article-title":"The recent progress of peptide regulators for the Wnt\/\u03b2-catenin signaling pathway","volume":"10","author":"Zhang","year":"2023","journal-title":"Front. Med."},{"key":"2026012711211435400_bib114","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3390\/cancers12040902","article-title":"Drug development targeting the ubiquitin\u2013proteasome system (UPS) for the treatment of human cancers","volume":"12","author":"Zhang","year":"2020","journal-title":"Cancers"},{"key":"2026012711211435400_bib116","doi-asserted-by":"crossref","first-page":"116161","DOI":"10.1016\/j.ejmech.2024.116161","article-title":"Recent advances in the development of deubiquitinases inhibitors as antitumor agents","volume":"266","author":"Zheng","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"2026012711211435400_bib117","doi-asserted-by":"crossref","first-page":"216868","DOI":"10.1016\/j.canlet.2024.216868","article-title":"Isthmin-1 promotes growth and progression of colorectal cancer through the interaction with EGFR and YBX-1","volume":"590","author":"Zhou","year":"2024","journal-title":"Cancer Lett."}],"container-title":["Journal of Molecular Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jmcb\/advance-article-pdf\/doi\/10.1093\/jmcb\/mjaf027\/64110945\/mjaf027.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jmcb\/article-pdf\/17\/6\/mjaf027\/64110945\/mjaf027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jmcb\/article-pdf\/17\/6\/mjaf027\/64110945\/mjaf027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T16:21:33Z","timestamp":1769530893000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jmcb\/article\/doi\/10.1093\/jmcb\/mjaf027\/8239787"}},"subtitle":[],"editor":[{"given":"Weiwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":119,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,1,24]]}},"URL":"https:\/\/doi.org\/10.1093\/jmcb\/mjaf027","relation":{},"ISSN":["1674-2788","1759-4685"],"issn-type":[{"value":"1674-2788","type":"print"},{"value":"1759-4685","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,6]]},"article-number":"mjaf027"}}